🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Iadademstat is being studied as a treatment for subjects with Relapsed or R...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2022-11-14
Trial ID
NCT05546580
Treatments Being Tested
This study is being done to evaluate the safety, tolerability and antitumor...
Status
Terminated
Location
City of Hope National Medical Center
Start Date
2020-10-06
Trial ID
NCT04477291
Treatments Being Tested
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested
This research is being done to assess the therapeutic efficacy and safety o...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
Start Date
2022-03-01
Trial ID
NCT05177731
Treatments Being Tested
This phase I trial is studying the safety, side effects, and best dose of g...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2024-07-25
Trial ID
NCT06225427
The purpose of this study is to provide expanded access to ASP2215 for a si...
Status
No Longer Available
Location
Children's Hospital Los Angeles
Start Date
TBD
Trial ID
NCT03315299
Treatments Being Tested
The goal of this clinical trial is to estimate the rate (probability) of co...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-01-01
Trial ID
NCT06221683
The purpose of this study was to determine the clinical benefit of ASP2215 ...
Status
Completed
Location
Site US10011
Start Date
2015-10-20
Trial ID
NCT02421939
Gilteritinib is available in early access in France through Temporary Autho...
Status
Completed
Location
Amiens CHU
Start Date
2021-07-05
Trial ID
NCT05193448
The purpose of this study was to compare relapse-free survival between part...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-08-16
Trial ID
NCT02997202
Treatments Being Tested